Branded medicine preference can lead to higher costs for patients, as branded drugs are typically more expensive than their generic counterparts.
Patient choices may be influenced by marketing strategies promoting branded medicines, potentially leading to overlooking more cost-effective generic alternatives.
Health outcomes may be impacted if patients choose not to adhere to prescribed treatment regimens due to cost concerns associated with branded medications.
The placebo effect can play a role in perceived efficacy when patients believe branded medicines are superior, influencing health outcomes irrespective of actual drug efficacy.
Regulatory measures ensuring bioequivalence and safety of generic drugs can provide reassurance to patients considering generic options over branded medicines, promoting informed decision-making.
